Dr. Chaur-Jong Hu is the consultant of the Dementia Center in Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan. He is also a professor in Neurology and the Dean of the College of Medicine, Taipei Medical University, Taipei, Taiwan.

Dr. Hu obtained his medical degree from Taipei Medical University, Taipei, Taiwan in 1990. He completed the residency training in the Department of Neurology, Taipei Municipal Jen-Ai Hospital. He also has ever worked as a research fellow in the Department of Neurology, stroke center, Washington University School of Medicine, St. Louis, Missouri, USA. He established a laboratory focusing on molecular mechanisms of neurological diseases, including cell and animal researches in TMU campus. Dr Hu has extensive experience in global and domestic clinical trials of therapies for stroke, Alzheimer Disease and other neurological diseases. He has published over 250 peer-reviewed papers and 2 book chapters on the pathophysiology of ischemic injury of brain and use of botulinum toxin in neuropathic pain. 

Dr Hu is currently the executive supervision and ex-president of the Taiwan Neurological Society and ex-president of Taiwan Dementia society.  He is also a fellow of the American Heart Association (FAHA) and President of Vas-Cog Asia. 

We are working on molecular mechanisms of neurological diseases, more focusing on Alzheimer disease (AD) and vascular dementia (VaD). In our Lab., we have transgenic AD mouse model and VaD moue model by bilateral common carotid artery occlusion (BCCAO). We are trying new approaches for therapy. In addition, we have established one cohort of dementia and one cohort of post-stroke cognitive impairment. There are 4000 and over 500 patients in the cohorts respectively. The methodology in our Lab includes molecular biology, such as Western blotting, real time RNA, DNA genotyping, flow cytometry and  single cell RNAseq, animal MRI, PET imaging.